TRANSCARDIA
Mark Identification

TRANSCARDIA

Serial Number

97314595

Filing Date

Mar 16, 2022

Trademark by

TRANSCARDIA LLC

Classification Information

Scientific and technological consulting services, namely, providing medical and scientific research information in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical devices; Scientific and technological research, namely, providing information in the field of pharmaceutical preclinical and clinical research and development; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical device manufacturing; scientific research and development for medical purposes; compiling data for research purposes in the field of medical science and medical consultancy; design and testing for new product development relating to the aforementioned services

Computer and Scientific

Providing medical information, consultancy, and advisory services to medical professionals in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals and medical devices; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical evaluation services for patients of gene modification, organ transplants, xenotransplantation, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness

Medical, Beauty & Agricultural

Regulatory compliance consulting, namely consulting in the field of regulatory affairs including for pharmaceuticals, therapies, and medical devices in the preclinical, clinical and commercial stage

Personal